By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650



Company News
Isis Pharma (ISIS)' Collaboration To Discover And Develop Antisense Drugs For Cardiovascular, Metabolic And Renal Diseases With AstraZeneca PLC (AZN) Receives HSR Clearance 9/11/2015 6:42:22 AM
Isis Pharma (ISIS) To Present At Upcoming Investor Conferences 9/3/2015 7:28:22 AM
Isis Pharma (ISIS) Reports Financial Results And Highlights For Second Quarter 2015 8/4/2015 8:24:02 AM
Isis Pharma (ISIS) Reports Positive Data from KYNAMRO (mipomersen sodium) FOCUS FH Phase 3 Study In Patients With Severe Heterozygous Familial Hypercholesterolemia 8/4/2015 6:13:46 AM
Isis Pharma (ISIS) Nabs $65 Million Upfront in Antisense Deal With AstraZeneca PLC (AZN) 8/3/2015 6:01:22 AM
Isis Pharma (ISIS) Release: Positive Clinical Data From Volanesorsen Published In The New England Journal of Medicine 7/30/2015 11:36:38 AM
Webcast Alert: Isis Pharma (ISIS)' Second Quarter 2015 Financial Results Conference Call 7/28/2015 12:48:43 PM
Isis Pharma (ISIS) Reports Data From ISIS-TTR Rx In Patients With Transthyretin Amyloid-Related Cardiomyopathy 7/27/2015 10:09:15 AM
Isis Pharma (ISIS) Release: Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published In The Lancet 7/23/2015 8:48:29 AM
Isis Pharma (ISIS) Initiates Clinical Study Of ISIS-HTT Rx In Patients With Huntington's Disease 7/21/2015 7:54:17 AM